News Release

  • News
  • CYTLIMIC has concluded an agreement in respect to a third-party allocation of newly issued shares to CYTLIMIC underwritten by Fast Track Initiative, Inc., SMBC Venture Capital Co., Ltd., and NEC Capital Solutions Limited as part of reinforcing its healthcare business and commencing with the drug development business.
  • News
  • New company "CYTLIMIC Inc." established to promote development and application of therapeutic cancer vaccines (Date established: December 16, 2016.  Address: Shinagawa-ku, Tokyo.  Representative: Shun Doi, President and CEO)